Concepedia

Author

Carol L. Beglan

National Institute on Drug Abuse

Also Known As

Carol L. Beglan

10

Publications

177

Citations

7

H-Index

31

Concepts

All Affiliations

National Institute on Drug AbuseNational Institutes of Health
CL

About

Carol L. Beglan is an author at National Institute on Drug Abuse specializing in medicine, neuropharmacology, and neuroscience.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

98

2

Health Sciences

2

2

44

3

Social Sciences

2

2

33

4

Anesthesia

1

1

21

5

Cell Biology

1

1

21

Carol L. Beglan

×

6

Publications

160

Citations

6

H-Index

YearCitations

Naloxone Activation of μ-Opioid Receptors Mutated at a Histidine Residue Lining the Opioid Binding Cavity

Charles E. Spivak, Carol L. Beglan, Brian K. Seidleck,

Molecular Pharmacology

1997

62

Fluorescein-labeled naloxone binding to mu opioid receptors on live Chinese hamster ovary cells using confocal fluorescent microscopy

Barry W. Madsen, Carol L. Beglan, Charles E. Spivak

Journal of Neuroscience Methods

2000

23

Interaction of ascorbic acid with the neurotoxic effects of nmda and sodium nitroprusside

James A. Bell, Carol L. Beglan, Edythe D. London

Life Sciences

1995

22

Co-treatment with MK-801 potentiates naloxone-predpitated morphine withdrawal in the isolated spinal cord of the neonatal rat

James A. Bell, Carol L. Beglan

European Journal of Pharmacology

1995

21

Diffusion Delays and Unstirred Layer Effects at Monolayer Cultures of Chinese Hamster Ovary Cells: Radioligand Binding, Confocal Microscopy, and Mathematical Simulations

Charles E. Spivak, Murat Öz, Carol L. Beglan,

Cell Biochemistry and Biophysics

2006

21

MK-801 blocks the expression but not the development of tolerance to morphine in the isolated spinal cord of the neonatal rat

James A. Bell, Carol L. Beglan

European Journal of Pharmacology

1995

11

Page 1